As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 9/21/16  Aerie Pharmaceuticals Inc.        8-K:1,9     9/15/16    3:187K                                   Donnelley … Solutions/FA 
 9/15/16  Aerie Pharmaceuticals Inc.        424B5                  1:314K                                   Donnelley … Solutions/FA 
 9/15/16  Aerie Pharmaceuticals Inc.        8-K:7,9     9/15/16    2:25K                                    Donnelley … Solutions/FA 
 9/15/16  Aerie Pharmaceuticals Inc.        S-3ASR      9/15/16    3:216K                                   Donnelley … Solutions/FA 
 9/15/16  Aerie Pharmaceuticals Inc.        424B5                  1:421K                                   Donnelley … Solutions/FA 
 9/15/16  Aerie Pharmaceuticals Inc.        8-K:1,9     9/15/16    3:206K                                   Donnelley … Solutions/FA 

____________
¹	Filing/Form Types:
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	424B5	Prospectus – Primary Offering or Shelf Securities – New Facts or Events.
	S-3ASR	Automatic Shelf Registration Statement by a Well-Known Issuer — Form S-3.